Vicki Wood
ARTICLES BY THIS AUTHOR
- 11/30/2022
Leadership in the time of crisis: another missed opportunity
The children’s pain reliever shortage was an ideal opportunity for pharmacy leadership to step up with clear, rational, national messaging. Instead, once again, exhausted pharmacists—and the public—were left to jerry-rig their own solutions to a crisis. - 11/29/2022
Reader contest: Write to win!
Start your keyboards! Submit your short personal story for a chance to win a $500 gift card and be published on CanadianHealthcareNetwork.ca. - 11/28/2022
Don’t judge a cancer drug by its price: more costly doesn’t necessarily more effective
Canada could be overpaying hundreds of millions, expert suggests. - 11/23/2022
Ubrogepant will be the first oral CGRP antagonist for acute migraine in Canada
Health Canada approves Ubrelvy (ubrogepant) for treating acute migraine, with or without aura, in adults - 11/16/2022
TNFα-inhibitor biologics for rheumatic disease linked to the development of MS
Study examines risk of multiple sclerosis among users of antitumour necrosis factor alpha biologics in four Canadian provinces - 11/9/2022
When the pharmacy is hazardous to your health
We spend so much time taking care of patients, but who is taking care of the pharmacy team? - 11/9/2022
Pharmacy students capture the "reel" Pharmacy U Vancouver
The pharmacy students behind the popular Instagram account TheRxDailyDose share their experience at Pharmacy U Vancouver in a short video. - 10/25/2022
CE lessons from the Pharmacy Practice + Business editorial team
Are you looking for practical Continuing Education on current topics? Check out these CE lessons prepared by our editorial team at Pharmacy Practice + Business - 10/24/2022
Pharmacy Practice + Business' Martha Porado recognized as 'emerging talent'
Managing editor of CanadianHealthcareNetwork.ca responsible for both pharmacy and the Medical Post newsletters - 10/12/2022
Emerging Omicron subvariants have potential to lead to a spike in COVID-19 cases
Reduced or abandoned public health measures speculated to be enhancing the ability of Omicron to develop more immune-evading subvariants.
